J. Kulkosky

发表

HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy.

R. Pomerantz, G. Nunnari, Yan Xu, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure.

A. Skalka, D. Bizub-Bender, J. Kulkosky, 1994, AIDS research and human retroviruses.

The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.

E. Argyris, R. Pomerantz, K. Williams, 2004, Virology.

U-Mediated Inhibition of Loss of Alloantigen Responsiveness and Viral Replication in Human CD 4 + T Cell Clones Exposed to Human Immunodeficiency Virus In Vitro

Jeffrey, David, Steven, 2013 .

The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro

A. Skalka, R. Katz, G. Merkel, 1990, Cell.

Location of oligo(uridylic acid) sequences within messenger ribonucleic acid molecules of HeLa cells.

M. Edmonds, W. Wood, J. Kulkosky, 1985, Biochemistry.

Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element

J. Laurence, P. Miller, J. Kulkosky, 1991, Journal of virology.

PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.

J. Laurence, S. Friedman, J. Kulkosky, 1987, The Journal of clinical investigation.

Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons

R. Pomerantz, M. Mukhtar, J. Kulkosky, 2011, Journal of NeuroVirology.

Characterization of a naphthalene derivative inhibitor of retroviral integrases.

I. Weber, R. Harrison, R. Daniel, 2004, AIDS research and human retroviruses.

Human immunodeficiency virus type 1 Vpr alters bone marrow cell function.

D. Prockop, R. Pomerantz, A. Srinivasan, 1999, Blood.

A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: characterization of a cellular protein and its relationship to p15E.

R. Snyderman, J. Laurence, J. Kulkosky, 1990, Cellular immunology.

Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases

A. Skalka, K. Jones, R. Katz, 1992, Molecular and cellular biology.

Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity.

J. Laurence, J. Kulkosky, A. Saunders, 1987, Science.

HIV type 1 cervicovaginal reservoirs in the era of HAART.

P. Nyirjesy, I. Frank, R. Pomerantz, 2005, AIDS research and human retroviruses.

Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs

J. Kulkosky, L. McKernan, David Momjian, 2012, Advances in virology.

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

M. Boyd, R. Pomerantz, G. Dornadula, 2001, Blood.

Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions.

A. Skalka, R. Katz, J. Kulkosky, 1990, Journal of acquired immune deficiency syndromes.

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

M. Thomson, Feng-xiang Wang, E. Argyris, 2005, The Journal of clinical investigation.

Pathogenesis of HIV-1 Infection Within Bone Marrow Cells

R. Pomerantz, G. Nunnari, D. Phinney, 2000, Leukemia & lymphoma.

Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase

A. Skalka, R. Pomerantz, L. Duan, 1996, Journal of Virology.

Molecular mechanism of retroviral DNA integration.

A. Skalka, J. Kulkosky, 1994, Pharmacology & therapeutics.

Retroviral integrase domains: DNA binding and the recognition of LTR sequences.

A. Skalka, R. Katz, J. Kulkosky, 1991, Nucleic acids research.

In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months

Alan S. Perelson, Hui Zhang, Geethanjali Dornadula, 2003, Journal of Virology.

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

Feng-xiang Wang, I. Frank, R. Pomerantz, 2003, AIDS research and human retroviruses.

The Elusive Nature Toward a Cure for HIV

J. Kulkosky, Muhammet Dria, 2018 .

In Vivo Effects of Antiviral Protein Kinase C Modulators on Zebrafish Development and Survival

Richard V. N. Davis, J. Kulkosky, J. Rhodes, 2011, ISRN toxicology.

HIV and AIDS: Myths, Facts, and the Future

G. Nunnari, J. Kulkosky, 2005 .

Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents.

D. Hamer, R. Pomerantz, Yan Xu, 2004, AIDS research and human retroviruses.

Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.

R. Pomerantz, J. Kulkosky, Joseph Kulkosky, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seminal reservoirs during an HIV type 1 eradication trial.

R. Pomerantz, G. Nunnari, Yan Xu, 2005, AIDS research and human retroviruses.

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.

Giuseppe Nunnari, Hui Zhang, A. Haase, 2002, The Journal of infectious diseases.

High-Frequency Epigenetic Repression and Silencing of Retroviruses Can Be Antagonized by Histone Deacetylase Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones Is Restricted by Additional Mechanisms

A. Skalka, E. Nicolas, R. Katz, 2007, Journal of Virology.

Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase.

A. Skalka, R. Katz, G. Merkel, 1995, Virology.

HIV DNA integration: observations and interferences.

A. Skalka, J. Kulkosky, 1990, Journal of acquired immune deficiency syndromes.

HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.

J. Kulkosky, Stacie Bray, 2006, Current HIV research.

Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle by Targeting Human Immunodeficiency Virus Type 1 Integrase

A. Skalka, R. Pomerantz, L. Duan, 1998, Journal of Virology.

Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.

L. Duan, R. Pomerantz, J. Kulkosky, 2000, Journal of human virology.

Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo.

R. Pomerantz, S. Calarota, Yan Xu, 2003, Virology.

Analyses of HIV Integration Components

A. Skalka, J. Kulkosky, K. Jones, 1991 .

A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.

R. Pomerantz, J. Kulkosky, M. Bouhamdan, 1999, Virology.